Loading...
Target Population: Oncologists, hematologists, primary-care providers
Venous thromboembolism (VTE) is a common complication of malignant disease, and VTE treatment for patients with cancer is similar to that for patients without cancer. Occasionally, however, thrombi extend or recur in cancer patients despite anticoagulant therapy, or patients experience chemotherapy-induced thrombocytopenia or develop bleeding because a tumor has eroded blood vessels. Here are key recommendations to help clinicians manage difficult issues in patients with cancer-associated thrombosis.